Piermont Capital Management Inc. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2016$330,000
-68.8%
158,788
+9.2%
0.08%
-71.5%
Q2 2016$1,057,000
+174.5%
145,418
+94.9%
0.27%
+122.8%
Q1 2016$385,000
-36.2%
74,595
+3.8%
0.12%
-35.9%
Q4 2015$603,000
+45.0%
71,850
+22.0%
0.19%
+41.2%
Q3 2015$416,000
-36.6%
58,8700.0%0.14%
-31.3%
Q2 2015$656,00058,8700.20%
Other shareholders
NOVAVAX INC shareholders Q1 2016
NameSharesValueWeighting ↓
BB BIOTECH AG 8,330,000$10,496,0000.39%
Alden Global Capital LLC 640,500$807,0000.28%
Quantitative Investment Management, LLC 3,784,100$4,767,0000.12%
Eventide Asset Management 1,449,700$1,827,0000.12%
Bellevue Group AG 325,000$410,0000.08%
Virtus ETF Advisers LLC 196,162$247,0000.07%
Rock Springs Capital Management LP 820,000$1,033,0000.07%
Quantbot Technologies LP 462,250$582,0000.06%
Traynor Capital Management, Inc. 43,361$55,0000.04%
Tekla Capital Management LLC 571,000$719,0000.03%
View complete list of NOVAVAX INC shareholders